Metraipolis › archive › dc_28d08f376b96

Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities — Europe PMC PMID:42279327

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42279327
DOI
10.3390/cancers18111744
License (as archived)
solo-consultazione
Archived
2026-11-01T05:48:48.458Z
SHA-256 of the archived text
e353bd24691f5d759c9936d40c0057742518740dd46b574c02ed959e43260e43
Stable URL of this page
https://metraipolis.com/documento/dc_28d08f376b96

How to cite

Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities — Europe PMC PMID:42279327 — Europe PMC (en), https://europepmc.org/article/MED/42279327 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_28d08f376b96 (Metraipolis archive dc_28d08f376b96, sha256 e353bd24691f5d759c9936d40c0057742518740dd46b574c02ed959e43260e43)
BibTeX
@misc{dc28d08f376b96,
  title = {Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities — Europe PMC PMID:42279327},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42279327},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_28d08f376b96; sha256 e353bd24691f5d759c9936d40c0057742518740dd46b574c02ed959e43260e43},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279327. Agents can read the archived copy with the MCP tool read_document.